Skip to main content
main-content
Top

10-25-2017 | Cardiovascular disorders | Review | Article

Dietary Patterns and Cardiovascular Disease Prevention among Patients with Diabetes

Journal: Current Nutrition Reports

Authors: Yuta Ishikawa, Elisabeth Lilian Pia Sattler

Publisher: Springer US

share
SHARE

Abstract

Purpose of Review

This review summarizes the most recent literature on dietary patterns and their effects on cardiovascular health among patients with diabetes.

Recent Findings

Studies identified examined low-fat, low-carbohydrate, low-glycemic index, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean dietary patterns. A limited number of short-term studies showed that intake of low-fat, low-carbohydrate, and low-glycemic index dietary patterns reduced body weight and blood pressure among individuals with diabetes. Short-term consumption of the DASH dietary pattern reduced blood pressure, low-density lipoprotein cholesterol, and triglyceride levels in patients with diabetes. Most convincing evidence supports the effectiveness of Mediterranean dietary patterns in cardiovascular disease prevention by reducing cardiovascular risk factors and mortality among patients with diabetes, as supported by a prospective cohort study, randomized controlled trials, and meta-analyses.

Summary

Among the dietary patterns identified, Mediterranean dietary patterns should be considered as primary nutritional recommendation for cardiovascular disease prevention among individuals with diabetes.
Literature
1.
Feigin V. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544. CrossRef
2.
Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: a review of contemporary guidance and literature. JRSM Cardiovasc Dis. 2017;6:2048004016687211. PubMedPubMedCentral
3.
Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:e354–471. CrossRefPubMed
4.
Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DEJ, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e663–828. CrossRefPubMed
5.
Eckel RH, Jakicic JM, Ard JD, Hubbard VS, de Jesus JM, Lee I-M, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology American/Heart Association Task Force on Practice Guidelines. Circulation. 2014;129 (25 Suppl 2):S76–99.
6.
Smith SCJ, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124:2458–73. CrossRefPubMed
7.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DEJ, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240–327. CrossRefPubMed
8.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–81. https://​doi.​org/​10.​1093/​eurheartj/​ehw106. CrossRefPubMedPubMedCentral
9.
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. CrossRefPubMedPubMedCentral
10.
Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services; 2017.
11.
Jansson SP, Andersson DK, Svärdsudd K. Mortality trends in subjects with and without diabetes during 33 years of follow-up. Diabetes Care. 2010;33(3):551–6. CrossRefPubMed
12.
Quispe R, Martin SS, Jones SR. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2016;23(2):150–6. https://​doi.​org/​10.​1097/​med.​0000000000000241​. CrossRefPubMed
13.
Quispe R, Manalac RJ, Faridi KF, Blaha MJ, Toth PP, Kulkarni KR, et al. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: the Very Large Database of Lipids-4 (VLDL-4) study. Atherosclerosis. 2015;242(1):243–50. CrossRefPubMed
14.
Sniderman AD, Wolfson C, Teng B, Franklin FA, Bachorik PS, Kwiterovich PO. Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med. 1982;97(6):833–9. CrossRefPubMed
15.
American Diabetes Association. Lifestyle management. Sec. 4. Standards of medical care in diabetes—2017. Diabetes Care. 2017;40(Suppl. 1):S33–43. CrossRef
16.
Watson N, Dyer K, Buckley J, Brinkworth G, Coates A, Parfitt G, et al. Effects of low-fat diets differing in protein and carbohydrate content on cardiometabolic risk factors during weight loss and weight maintenance in obese adults with type 2 diabetes. Nutrients. 2016;8(5):289. CrossRefPubMedCentral
17.
Ley SJ, Metcalf PA, Scragg RK, Swinburn BA. Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Res Clin Pract. 2004;63(2):103–12. CrossRefPubMed
18.
Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS, Brehm BJ, et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166(3):285–93. CrossRefPubMed
19.
Perk J, De Backer G, Gohlke H, Graham I, Reiner Ž, Verschuren WM, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Int J Behav Med. 2012;19(4):403–88. CrossRefPubMed
20.
Guldbrand H, Dizdar B, Bunjaku B, Lindström T, Bachrach-Lindström M, Fredrikson M, et al. In type 2 diabetes, randomisation to advice to follow a low-carbohydrate diet transiently improves glycaemic control compared with advice to follow a low-fat diet producing a similar weight loss. Diabetologia. 2012;55(8):2118–27. CrossRefPubMedPubMedCentral
21.
Hooper L, Abdelhamid A, Moore HJ, Douthwaite W, Skeaff CM, Summerbell CD. Effect of reducing total fat intake on body weight: systematic review and meta-analysis of randomised controlled trials and cohort studies. BMJ. 2012;345:e7666. CrossRefPubMedPubMedCentral
22.
Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34(7):1481–6. CrossRefPubMedPubMedCentral
23.
Group LAR. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;2013(369):145–54.
24.
Tay J, Luscombe-Marsh ND, Thompson CH, Noakes M, Buckley JD, Wittert GA, et al. A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial. Diabetes Care. 2014;37(11):2909–18. CrossRefPubMed
25.
Hite AH, Berkowitz VG, Berkowitz K. Low-carbohydrate diet review: shifting the paradigm. Nutr Clin Pract. 2011;26(3):300–8. CrossRefPubMed
26.
Wylie-Rosett J, Aebersold K, Conlon B, Isasi CR, Ostrovsky NW. Health effects of low-carbohydrate diets: where should new research go? Curr Diabetes Rep. 2013;13(2):271–8. CrossRef
27.
Konner M, Eaton SB. Paleolithic nutrition: twenty-five years later. Nutr Clin Pract. 2010;25(6):594–602. CrossRefPubMed
28.
Eaton SB, Sr E, Konner MJ. Paleolithic nutrition revisited: a twelve-year retrospective on its nature and implications. Eur J Clin Nutr. 1997;51(4):207–16. CrossRefPubMed
29.
Eaton SB, Eaton Iii SB. Paleolithic vs. modern diets—selected pathophysiological implications. Eur J Nutr. 2000;39(2):67–70. CrossRefPubMed
30.
Meng Y, Bai H, Wang S, Li Z, Wang Q, Chen L. Efficacy of low carbohydrate diet for type 2 diabetes mellitus management: a systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2017;131:124–31.
31.
Snorgaard O, Poulsen GM, Andersen HK, Astrup A. Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2017;5(1):e000354. CrossRefPubMedPubMedCentral
32.
Hussain A, Ali I, Ijaz M, Rahim A. Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia. Ther Adv Endocrinol Metab. 2017;8(4):51–7. CrossRefPubMedPubMedCentral
33.
Davis NJ, Tomuta N, Schechter C, Isasi CR, Segal-Isaacson CJ, Stein D, et al. Comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes. Diabetes Care. 2009;32(7):1147–52. https://​doi.​org/​10.​2337/​dc08-2108. CrossRefPubMedPubMedCentral
34.
Goldstein T, Kark JD, Berry EM, Adler B, Ziv E, Raz I. The effect of a low carbohydrate energy-unrestricted diet on weight loss in obese type 2 diabetes patients—a randomized controlled trial. e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism. 2011;6(4):e178–e86. CrossRef
35.
Otten J, Stomby A, Waling M, Isaksson A, Tellström A, Lundin-Olsson L, et al. Benefits of a Paleolithic diet with and without supervised exercise on fat mass, insulin sensitivity, and glycemic control: a randomized controlled trial in individuals with type 2 diabetes. Diabetes Metab Res Rev. 2017;33(1). https://​doi.​org/​10.​1002/​dmrr.​2828.
36.
Iqbal N, Vetter ML, Moore RH, Chittams JL, Dalton-Bakes CV, Dowd M, et al. Effects of a low-intensity intervention that prescribed a low-carbohydrate vs. a low-fat diet in obese, diabetic participants. Obesity. 2010;18(9):1733–8. CrossRefPubMed
37.
Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb Vasc Biol. 1992;12(8):911–9. CrossRef
38.
Floegel A, Pischon T. Low carbohydrate-high protein diets. London: BMJ. 2012;344:e3801.
39.
McCullough ML, Feskanich D, Stampfer MJ, Giovannucci EL, Rimm EB, Hu FB, et al. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr. 2002;76(6):1261–71. PubMed
40.
Krebs JD, Bell D, Hall R, Parry-Strong A, Docherty PD, Clarke K, et al. Improvements in glucose metabolism and insulin sensitivity with a low-carbohydrate diet in obese patients with type 2 diabetes. J Am Coll Nutr. 2013;32(1):11–7. CrossRefPubMed
41.
Yamada Y, Uchida J, Izumi H, Tsukamoto Y, Inoue G, Watanabe Y, et al. A non-calorie-restricted low-carbohydrate diet is effective as an alternative therapy for patients with type 2 diabetes. Intern Med. 2014;53(1):13–9. CrossRefPubMed
42.
Brand-Miller J, Hayne S, Petocz P, Colagiuri S. Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care. 2003;26(8):2261–7. CrossRefPubMed
43.
Jenkins DJ, Kendall CW, Augustin LS, Mitchell S, Sahye-Pudaruth S, Mejia SB, et al. Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med. 2012;172(21):1653–60. CrossRefPubMed
44.
Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. 2013;97(3):505–16. CrossRefPubMed
45.
National Institute of Health. Description of the DASH Eating Plan. 2015. https://​www.​nhlbi.​nih.​gov/​health/​health-topics/​topics/​dash. Accessed 15 Sep 2017.
46.
Paula TP, Viana LV, Neto AT, Leitao CB, Gross JL, Azevedo MJ. Effects of the DASH diet and walking on blood pressure in patients with type 2 diabetes and uncontrolled hypertension: a randomized controlled trial. J Clin Hypertens. 2015;17(11):895–901. CrossRef
47.
de Paula TP, Steemburgo T, de Almeida JC, Dall'Alba V, Gross JL, de Azevedo MJ. The role of Dietary Approaches to Stop Hypertension (DASH) diet food groups in blood pressure in type 2 diabetes. Br J Nutr. 2012;108(1):155–62. CrossRefPubMed
48.
Ard JD, Grambow SC, Liu D, Slentz CA, Kraus WE, Svetkey LP. The effect of the PREMIER interventions on insulin sensitivity. Diabetes Care. 2004;27(2):340–7. CrossRefPubMed
49.
Steffen LM, Kroenke CH, Yu X, Pereira MA, Slattery ML, Van Horn L, et al. Associations of plant food, dairy product, and meat intakes with 15-y incidence of elevated blood pressure in young black and white adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr. 2005;82(6):1169–77. PubMed
50.
van Mierlo LA, Greyling A, Zock PL, Kok FJ, Geleijnse JM. Suboptimal potassium intake and potential impact on population blood pressure. Arch Intern Med. 2010;170(16):1501–2. CrossRefPubMed
51.
Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336(16):1117–24. CrossRefPubMed
52.
Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001;344(1):3–10. CrossRefPubMed
53.
Hayashino Y, Jackson JL, Fukumori N, Nakamura F, Fukuhara S. Effects of supervised exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2012;98(3):349–60. CrossRefPubMed
54.
Qiu S, Cai X, Schumann U, Velders M, Sun Z, Steinacker JM. Impact of walking on glycemic control and other cardiovascular risk factors in type 2 diabetes: a meta-analysis. PLoS One. 2014;9(10):e109767. CrossRefPubMedPubMedCentral
55.
Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279–90. CrossRefPubMed
56.
•• Bonaccio M, Di Castelnuovo A, Costanzo S, Persichillo M, De Curtis A, Donati MB, et al. Adherence to the traditional Mediterranean diet and mortality in subjects with diabetes. Prospective results from the MOLI-SANI study. Eur J Prev Cardiol. 2016;23(4):400–7. This cohort study provides evidence that Mediterranean dietary patterns may reduce CVD mortality among individuals with type 2 diabetes. CrossRefPubMed
57.
Veissi M, Anari R, Amani R, Shahbazian H, Latifi SM. Mediterranean diet and metabolic syndrome prevalence in type 2 diabetes patients in Ahvaz, southwest of Iran. Diabetes Metab Syndr : Clin Res Rev. 2016;10(2):S26–S9. CrossRef
58.
• Huo R, Du T, Xu Y, Xu W, Chen X, Sun K, et al. Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta-analysis. Eur J Clin Nutr. 2015;69(11):1200. This meta-analysis indicates the impacts of Mediterranean dietary patterns on cardiovascular disease risk factors among individuals with type 2 diabetes. CrossRefPubMed
59.
Carter P, Achana F, Troughton J, Gray L, Khunti K, Davies M. A Mediterranean diet improves HbA1c but not fasting blood glucose compared to alternative dietary strategies: a network meta-analysis. J Hum Nutr Diet. 2014;27(3):280–97. CrossRefPubMed
60.
Embree GG, Samuel-Hodge CD, Johnston LF, Garcia BA, Gizlice Z, Evenson KR, et al. Successful long-term weight loss among participants with diabetes receiving an intervention promoting an adapted Mediterranean-style dietary pattern: the Heart Healthy Lenoir Project. BMJ Open Diabetes Res Care. 2017;5(1):e000339. CrossRefPubMedPubMedCentral
61.
Jacobs DR, Gross MD, Tapsell LC. Food synergy: an operational concept for understanding nutrition. Am J Clin Nutr. 2009;89(5):1543S–8S. CrossRefPubMedPubMedCentral
62.
Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;2008(359):229–41. CrossRef
63.
Elhayany A, Lustman A, Abel R, Attal-Singer J, Vinker S. A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study. Diabetes Obes Metab. 2010;12(3):204–9. CrossRefPubMed
64.
Van Der Heijden AA, van’t Riet E, Bot SD, Cannegieter SC, Stehouwer CD, Baan CA, et al. Risk of a recurrent cardiovascular event in individuals with type 2 diabetes or intermediate hyperglycemia. Diabetes Care. 2013;36(11):3498–502. CrossRefPubMedPubMedCentral
65.
Apostolopoulou M, Michalakis K, Miras A, Hatzitolios A, Savopoulos C. Nutrition in the primary and secondary prevention of stroke. Maturitas. 2012;72(1):29–34. CrossRefPubMed

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

GLP-1 receptor agonists

Browse the latest news, clinical trial updates, and expert commentary.